Literature DB >> 9787927

Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register.

O Säynäjäkangas1, T Keistinen, T Tuuponen, S L Kivelä.   

Abstract

The incidence and age distribution of bronchiectasis is at present poorly known. The aim here was to describe the use made of hospital services by bronchiectasis patients in Finland over ten years and to estimate the incidence of this disease. Data on hospital admissions for bronchiectasis were obtained from the register maintained by the National Research and Development Centre for Welfare and Health. Admissions and new cases during the period 1983-1992 were calculated by age and sex in relation to the total population. There were 5,710 admissions for bronchiectasis and 1,928 new cases. The occurrence of cases treated in hospital was 4.9 per million person-years at age 0-14 years, 103.8 at 65 years or over and 38.9 in the total population. The estimated incidence of bronchiectasis is low in Finland, especially in childhood, and efforts aimed at its treatment should now be directed specifically at the elderly population, which continues to exert considerable pressure on even a relatively well developed health service in this respect.

Entities:  

Mesh:

Year:  1998        PMID: 9787927

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  7 in total

1.  New Zealand national incidence of bronchiectasis "too high" for a developed country.

Authors:  J Twiss; R Metcalfe; E Edwards; C Byrnes
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

Review 2.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

Review 3.  Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults.

Authors:  Khin Hnin; Chau Nguyen; Kristin V Carson; David J Evans; Michael Greenstone; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2015-08-13

4.  Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients.

Authors:  Pieter Christian Goeminne; Hans Scheers; Ann Decraene; Sven Seys; Lieven Joseph Dupont
Journal:  Respir Res       Date:  2012-03-16

Review 5.  The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents.

Authors:  Gabrielle B McCallum; Michael J Binks
Journal:  Front Pediatr       Date:  2017-02-20       Impact factor: 3.418

Review 6.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

7.  Prevalence and burden of bronchiectasis in a lung cancer screening program.

Authors:  Maria Sanchez-Carpintero Abad; Pablo Sanchez-Salcedo; Juan P de-Torres; Ana B Alcaide; Luis M Seijo; Jesus Pueyo; Gorka Bastarrika; Javier J Zulueta; Arantza Campo
Journal:  PLoS One       Date:  2020-04-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.